ADGRL3 and Alzheimer disease: Interestingly, following incubation with CL3, we observed a significant decrease of these HMW tau aggregates as shown in the Tau 5 quantification for DLB (Fig. 3B), AD (Fig. 3D), and PSP brain–derived tau oligomers (Fig. 3F).